Svennilson Peter current holdings: USA Other Stocks
Svennilson Peter reported $0.59 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 4 positions, in its Form 13F for the quarter ended 2020-09-30; the largest are NGM Biopharmaceuticals Inc, RAPT Therapeutics Inc, Constellation Pharmceticls I.
- NGM Biopharmaceuticals Inc: Country of operation United States; Class COM; Shares 18,017,932; Value $286,665,000.
- RAPT Therapeutics Inc: Country of operation United States; Class COM; Shares 5,630,497; Value $181,302,000.
- Constellation Pharmceticls I: Country of operation —; Class COM; Shares 6,051,376; Value $122,601,000.
- Gritstone Oncology Inc: Country of operation United States; Class COM; Shares 869,493; Value $2,304,000.
Form 13F-HR as filed (SEC CIK 1606074): quarter ended 2020-09-30, filed 2020-11-04. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|---|---|---|---|---|---|
| NGM Biopharmaceuticals Inc CUSIP 62921N105 | United States | COM | 18,017,932 | $286,665,000 | 2020-09-30 | 2020-11-04 |
| RAPT Therapeutics Inc CUSIP 75382E109 | United States | COM | 5,630,497 | $181,302,000 | 2020-09-30 | 2020-11-04 |
| Constellation Pharmceticls I CUSIP 210373106 | COM | 6,051,376 | $122,601,000 | 2020-09-30 | 2020-11-04 | |
| Gritstone Oncology Inc CUSIP 39868T105 | United States | COM | 869,493 | $2,304,000 | 2020-09-30 | 2020-11-04 |
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||